Dannon Launches New Activia Product, DanActive, Forms Partnerships
This article was originally published in The Tan Sheet
Executive Summary
Dannon will launch Activia Light nonfat yogurt in the U.S. following the successful introduction of the original version of the product, the firm announced Jan. 22
You may also be interested in...
Sales & Earnings In Brief
Nutrition 21: Total revenues for the Purchase, N.Y.-based firm's fiscal 2007 Q2 (ended Dec. 31, 2006) were $9.4 mil. compared to $2.1 mil. for the prior-year period. "We are beginning to benefit from the synergies we expected from our Iceland Health acquisition," Nutrition 21 CEO Paul Intlekofer says in a Feb. 13 release. Nutrition 21 announced in August 2006 its plan to acquire Iceland Health (1"The Tan Sheet," Aug. 21, 2006, p. 5). Intlekofer also says the firm is on schedule to begin national distribution of both Iceland Health Maximum Strength Omega-3 and Iceland Health Joint Relief products between March and May at major food, drug and mass retailers. "By the end of our fiscal year on June 30, we expect to have five branded product lines in national distribution that address pre-diabetes, diabetes, cardiovascular health, arthritis/joint health and HIV," Intlekofer says...
Sales & Earnings In Brief
Nutrition 21: Total revenues for the Purchase, N.Y.-based firm's fiscal 2007 Q2 (ended Dec. 31, 2006) were $9.4 mil. compared to $2.1 mil. for the prior-year period. "We are beginning to benefit from the synergies we expected from our Iceland Health acquisition," Nutrition 21 CEO Paul Intlekofer says in a Feb. 13 release. Nutrition 21 announced in August 2006 its plan to acquire Iceland Health (1"The Tan Sheet," Aug. 21, 2006, p. 5). Intlekofer also says the firm is on schedule to begin national distribution of both Iceland Health Maximum Strength Omega-3 and Iceland Health Joint Relief products between March and May at major food, drug and mass retailers. "By the end of our fiscal year on June 30, we expect to have five branded product lines in national distribution that address pre-diabetes, diabetes, cardiovascular health, arthritis/joint health and HIV," Intlekofer says...
Sales & Earnings In Brief
Nutrition 21: Total revenues for the Purchase, N.Y.-based firm's fiscal 2007 Q2 (ended Dec. 31, 2006) were $9.4 mil. compared to $2.1 mil. for the prior-year period. "We are beginning to benefit from the synergies we expected from our Iceland Health acquisition," Nutrition 21 CEO Paul Intlekofer says in a Feb. 13 release. Nutrition 21 announced in August 2006 its plan to acquire Iceland Health (1"The Tan Sheet," Aug. 21, 2006, p. 5). Intlekofer also says the firm is on schedule to begin national distribution of both Iceland Health Maximum Strength Omega-3 and Iceland Health Joint Relief products between March and May at major food, drug and mass retailers. "By the end of our fiscal year on June 30, we expect to have five branded product lines in national distribution that address pre-diabetes, diabetes, cardiovascular health, arthritis/joint health and HIV," Intlekofer says...